Alterity Therapeutics Ltd. (ATHE) - Kompaniyaning xususiy kapitali

Ommaviy kompaniya Alterity Therapeutics Ltd (ATHE) logotipi

Alterity Therapeutics (ATHE) kompaniyasining ilm-fanga asoslangan jamoasi kam uchraydigan miya patologiyalari uchun terapiya vositalarini ishlab chiqishni maqsad qilgan va o'zining ulkan rejalarini moliyalashtirish uchun faol ravishda kapital jalb qilmoqda. Kompaniyaning texnik infratuzilmasi barqaror ishlamoqda, maxsus laboratoriyalar esa uskunalar nosozliklarisiz biomateriallarni qayta ishlamoqda. Hozirda 0.03 darajasida bo'lgan ushbu narxlar grafigi, dastlabki klinik sinovlar natijalari e'lon qilinishi va Parkinson kasalligi uchun innovatsion oral terapiya vositasi ishlab chiqilishi fonida aktivning dinamikasini aks ettiradi.

ATHE Alterity Therapeutics Ltd Balans kapitallashuvi (04.07.2022 - 28.10.2026)

Alterity Therapeutics Ltd (ATHE) kompaniyasi koʻrsatkichlari kesimi va tahlili

- narx va narxlar bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi Alterity Therapeutics|ATHE - Tahlilchilar konsensus prognozi
- bozor kapitallashuvi bo'yicha ma'lumotlar:
Bozor qiymati Alterity Therapeutics Ltd.|ATHE - Kompaniyaning to‘liq qiymati
- balans kapitallashuvi bo'yicha ma'lumotlar:
Bitta aksiya hisobiga xususiy kapital Alterity Therapeutics|ATHE - Balans kapitallashuvi|Bozor qiymatining balans qiymatiga koeffitsiyenti alteritytherapeutics.com|ATHE - Kompaniyaning yakuniy aktivlari
- qarz va likvidlik bo'yicha ma'lumotlar:
Umumiy qarzning kapitalga nisbati Alterity Therapeutics|ATHE - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Alterity Therapeutics|ATHE - Kompaniya qarzlari|Balans qiymatiga qarzlar Alterity Therapeutics Ltd.|ATHE - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzlari Alterity Therapeutics
Kompaniyaning jamlanma tahlili:ATHE - Alterity Therapeutics Limited
alteritytherapeutics.com yetakchi tovari

Alterity Therapeutics (ATHE) kompaniyasining kredit sifatini baholash uchun tahlilchi joriy kitob kapitalizatsiyasi metrikasidan foydalanadi, u bozor shovqinlarini filtrlagan holda, sof aktivlar dinamikasi orqali ishlab chiqarish quvvatining tiklanishining real sur'atini o'lchaydi. Tashqi laboratoriyalarga kuchli bog'liqlik va tartibga soluvchi cheklovlarni hisobga olgan holda, ushbu ko'rsatkich biznesning haqiqiy barqarorligini aniqlaydi va spekulyativ narx tebranishlaridan qat'i nazar, tendentsiyaning teskari yo'nalishga o'zgarishidan signal beradi.

Alterity Therapeutics raqobatchilari tahlili

BIIB - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi NBIX|RGC (regencellbioscience.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Axsome Therapeutics, Inc. (AXSM)|Buxgalteriya kapitallashuvi ACADIA Pharma|Xenon Pharmaceuticals Inc - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Viking Therapeutics Corp VKTX|Kompaniyaning sof aktivlari SUPN (Supernus Pharmaceuticals)|catalystpharma.com - Balans kapitallashuvi|Kompaniyaning balans qiymati Denali Therapeutics Inc. (DNLI)|HRMY: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati BHVN|Amylyx Corp (AMLX) - Kompaniyaning xususiy kapitali|TRVI (Trevi Therapeutics) - Balans kapitallashuvi|Balans kapitallashuvi PRAX|Kompaniyaning balans qiymati Anavex Life Sciences Corp. (AVXL)|Kompaniyaning balans qiymati CeriBell Inc CBLL|Kompaniyaning sof aktivlari prothena.com (PRTA)|Jami sof aktivlar Alector Inc. ALEC|ANNX (Annexon, Inc.) - Balans kapitallashuvi|OMER: Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Neurogene NGNE|AC Immune S.A. (ACIU) - Kompaniyaning buxgalteriya qiymati|VYGR: Balans kapitallashuvi|Biznesning balans bahosi Neumora Corp (NMRA)|Kompaniyaning sof aktivlari Scilex Holding Company|Jami sof aktivlar tevogen.com TVGN|ACOG: Kompaniyaning sof aktivlari|CGTX - Kompaniyaning xususiy kapitali|Kompaniyaning sof aktivlari Inhibikase (IKT)|Cassava Pharma (SAVA) - Kompaniyaning buxgalteriya qiymati|ASRT - Kompaniyaning sof aktivlari|Coya Therapeutics (COYA) - Jami sof aktivlar|VTGN - Balans kapitallashuvi|Kompaniyaning buxgalteriya qiymati Ovid Rx|Acumen Pharma - Balans kapitallashuvi|Kompaniyaning xususiy kapitali CRVO (CervoMed Corporation)|Kompaniyaning balans qiymati Clene|Kompaniyaning buxgalteriya qiymati PepGen Inc PEPG|Jupiter Neurosciences Inc - Balans kapitallashuvi|RLMD: Balans kapitallashuvi|Kompaniyaning balans qiymati Annovis Bio Corp (ANVS)|Grace Therapeutics (GRCE) - Sof aktivlar qiymati|Balans kapitallashuvi AIFF (Firefly Neuroscience, Inc)|Kompaniyaning xususiy kapitali ANEW Medical, Inc. (KLTO)|Kompaniyaning sof aktivlari NRSN|Balans kapitallashuvi Reviva Pharmaceuticals Holdings Inc. RVPH|Kompaniyaning sof aktivlari MetaVia (MTVA)|Jami sof aktivlar NeurAxis Inc NRXS|Balans kapitallashuvi HSDT (Helius Medical Technologies Inc.)|PASG - Biznesning balans bahosi|NEUP (bionomics.com.au) - Balans kapitallashuvi|NERV (Minerva Neurosciences Inc) - Kompaniyaning sof aktivlari|ATHA: Kompaniyaning balans qiymati|Biznesning balans bahosi Addex|Balans kapitallashuvi ALZN|Balans kapitallashuvi cyclerion.com CYCN|Kompaniyaning sof aktivlari Protagenic Therapeutics, Inc. (PTIX)|Jami sof aktivlar Pasithea Therapeutics Corp KTTA|Balans kapitallashuvi Cortigent Medical (CRGT)|ATXI - Kompaniyaning buxgalteriya qiymati|Balans kapitallashuvi BCLI|CARA (caratherapeutics.com) - Kompaniyaning xususiy kapitali|Kompaniyaning balans qiymati Chromocell Therapeutics Corp. (CHRO)|Buxgalteriya kapitallashuvi Eliem|Intra-Cellular Therapies - Balans kapitallashuvi|Kompaniyaning xususiy kapitali Longboard LBPH|Kompaniyaning sof aktivlari MRNS (Marinus Pharmaceuticals)|nkgenbiotech.com - Balans kapitallashuvi|Kompaniyaning balans qiymati NeuroBo Pharmaceuticals, Inc. (NRBO)|SAGE: Kompaniyaning buxgalteriya qiymati|Kompaniyaning balans qiymati SNPX|Trevena Inc (TRVN) - Kompaniyaning xususiy kapitali|VIGL (Vigil Neuroscience Inc.) - Balans kapitallashuvi|Balans kapitallashuvi WENA|Kompaniyaning balans qiymati Cerevel Therapeutics, Inc. (CERE)